Bishal Debroy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bishal Debroy has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Kuntal Pal
Department of Bio-Sciences, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology, Vellore, India
3 shared publications - Arkajit De
Van Andel Institute Graduate School, Grand Rapids, USA
2 shared publications - Somdatta Bhattacharya
Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat-Barrackpore Road, Kolkata-700126, West Bengal, India
2 shared publications - Arijit Bhattacharya
AMR-Research Laboratory, Department of Biological Sciences, Adamas University
1 shared publication - Sribas Chowdhury
Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, India
1 shared publication
Latest Publications
- Open Access
- 3 December 2023
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 14 (6) , 100825
In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus
- 3 December 2023
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 14 (6) , 100825
Open AccessIn silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus
- Open Access
- 27 November 2023
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 21 (1) , 143-15
Designing a novel and combinatorial multi-antigenic epitope-based vaccine “MarVax” against Marburg virus—a reverse vaccinology and immunoinformatics approach
- 27 November 2023
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 21 (1) , 143-15
Open AccessDesigning a novel and combinatorial multi-antigenic epitope-based vaccine “MarVax” against Marburg virus—a reverse vaccinology and immunoinformatics approach
- Open Access
- 28 April 2023
- Published by Springer Nature in In Silico Pharmacology
- Vol. 11 (1) , 1-30
Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), possesses an important bifunctional nonstructural protein (nsp14) with a C-terminal N7-methyltransferase (N7-MTase) domain and an N-terminal domain with exoribonuclease (ExoN) activity that is required for maintaining high-fidelity viral replication. Viruses use the error-prone replication mechanism, which results in high mutation rates, to adapt quickly to stressful situations. The efficiency with which nsp14 removes mismatched nucleotides due to the presence of ExoN activity protects viruses from mutagenesis. We investigated the pharmacological role of the phytochemicals (Baicalein, Bavachinin, Emodin, Kazinol F, Lycorine, Sinigrin, Procyanidin A2, Tanshinone IIA, Tanshinone IIB, Tomentin A, and Tomentin E) against the highly conserved nsp14 protein using docking-based computational analyses in search of new potential natural drug targets. The selected eleven phytochemicals failed to bind the active site of N7-Mtase in the global docking study, while the local docking study identified the top five phytochemicals with high binding energy scores ranging from − 9.0 to − 6.4 kcal/mol. Procyanidin A2 and Tomentin A showed the highest docking score of − 9.0 and − 8.1 kcal/mol, respectively. Local docking of isoform variants was also conducted, yielding the top five phytochemicals, with Procyanidin A1 having the highest binding energy value of − 9.1 kcal/mol. The phytochemicals were later tested for pharmacokinetics and pharmacodynamics analysis for Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) which resulted in choosing Tomentin A as a potential candidate. The molecular dynamics simulations studies of nsp14 revealed significant conformational changes upon complex formation with the identified compound, implying that these phytochemicals could be used as safe nutraceuticals which will impart long-term immunological competence in the human population against CoVs. Graphical Abstract
- 28 April 2023
- Published by Springer Nature in In Silico Pharmacology
- Vol. 11 (1) , 1-30
Open AccessExploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), possesses an important bifunctional nonstructural protein (nsp14) with a C-terminal N7-methyltransferase (N7-MTase) domain and an N-terminal domain with exoribonuclease (ExoN) activity that is required for maintaining high-fidelity viral replication. Viruses use the error-prone replication mechanism, which results in high mutation rates, to adapt quickly to stressful situations. The efficiency with which nsp14 removes mismatched nucleotides due to the presence of ExoN activity protects viruses from mutagenesis. We investigated the pharmacological role of the phytochemicals (Baicalein, Bavachinin, Emodin, Kazinol F, Lycorine, Sinigrin, Procyanidin A2, Tanshinone IIA, Tanshinone IIB, Tomentin A, and Tomentin E) against the highly conserved nsp14 protein using docking-based computational analyses in search of new potential natural drug targets. The selected eleven phytochemicals failed to bind the active site of N7-Mtase in the global docking study, while the local docking study identified the top five phytochemicals with high binding energy scores ranging from − 9.0 to − 6.4 kcal/mol. Procyanidin A2 and Tomentin A showed the highest docking score of − 9.0 and − 8.1 kcal/mol, respectively. Local docking of isoform variants was also conducted, yielding the top five phytochemicals, with Procyanidin A1 having the highest binding energy value of − 9.1 kcal/mol. The phytochemicals were later tested for pharmacokinetics and pharmacodynamics analysis for Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) which resulted in choosing Tomentin A as a potential candidate. The molecular dynamics simulations studies of nsp14 revealed significant conformational changes upon complex formation with the identified compound, implying that these phytochemicals could be used as safe nutraceuticals which will impart long-term immunological competence in the human population against CoVs. Graphical Abstract